QILIAN INTERNATIONAL HOLDING (QLI) Stock Price & Overview
NASDAQ:QLI • KYG7307E1237
Current stock price
The current stock price of QLI is 5.41 USD. Today QLI is down by -6.08%. In the past month the price increased by 26.7%. In the past year, price increased by 27.37%.
QLI Key Statistics
- Market Cap
- 38.682M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.09
- Dividend Yield
- N/A
QLI Stock Performance
QLI Stock Chart
QLI Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to QLI. When comparing the yearly performance of all stocks, QLI is one of the better performing stocks in the market, outperforming 93.62% of all stocks.
QLI Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to QLI. The financial health of QLI is average, but there are quite some concerns on its profitability.
QLI Earnings
QLI Forecast & Estimates
QLI Groups
Sector & Classification
QLI Financial Highlights
Over the last trailing twelve months QLI reported a non-GAAP Earnings per Share(EPS) of -1.09. The EPS decreased by -3727.33% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -15.18% | ||
| ROE | -18.18% | ||
| Debt/Equity | 0.01 |
QLI Ownership
QLI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 28.18 | 921.899B | ||
| JNJ | JOHNSON & JOHNSON | 20.74 | 583.292B | ||
| MRK | MERCK & CO. INC. | 22.34 | 286.575B | ||
| PFE | PFIZER INC | 8.9 | 152.733B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.33 | 120.05B | ||
| ZTS | ZOETIS INC | 16.34 | 48.739B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.83 | 26.461B | ||
| VTRS | VIATRIS INC | 5.39 | 15.889B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.81 | 11.276B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 7.883B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 6.361B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 4.698B | ||
| LGND | LIGAND PHARMACEUTICALS | 23.9 | 4.217B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About QLI
Company Profile
Qilian International Holding Group Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Jiuquan, Gansu and currently employs 298 full-time employees. The company went IPO on 2021-01-12. Qilian International Holding Group Ltd is a China-based company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. Its main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.
Company Info
IPO: 2021-01-12
QILIAN INTERNATIONAL HOLDING
No. 152 Hongliang East 1St Street, No. 1703, Tianfu New District
Jiuquan GANSU 735000 CN
CEO: Zhanchang Xin
Employees: 298
Phone: 8609372689523
QILIAN INTERNATIONAL HOLDING / QLI FAQ
What does QILIAN INTERNATIONAL HOLDING do?
Qilian International Holding Group Ltd is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Jiuquan, Gansu and currently employs 298 full-time employees. The company went IPO on 2021-01-12. Qilian International Holding Group Ltd is a China-based company mainly engaged in the development, manufacture, marketing and sale of licorice products, oxytetracycline products, traditional Chinese medicine derivatives (TCMD) product, heparin product, sausage casings and fertilizers. The firm operates through three segments: Oxytetracycline & Licorice Products and TCMD segment, Fertilizer segment and Heparin Products and Sausage Casing segment. Its main brand is Qilian Shan. The firm principally operates its businesses within the domestic market.
Can you provide the latest stock price for QILIAN INTERNATIONAL HOLDING?
The current stock price of QLI is 5.41 USD. The price decreased by -6.08% in the last trading session.
What is the dividend status of QILIAN INTERNATIONAL HOLDING?
QLI does not pay a dividend.
What is the ChartMill technical and fundamental rating of QLI stock?
QLI has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
How is the valuation of QILIAN INTERNATIONAL HOLDING (QLI) based on its PE ratio?
QILIAN INTERNATIONAL HOLDING (QLI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.09).